Source link : https://www.newshealth.biz/health-news/g1-therapeutics-breast-cancer-drug-fails-in-late-stage-trial/
(Reuters) – G1 Therapeutics said on Monday its drug for a rare, aggressive form of breast cancer did not meet the main goal of overall survival in a late-stage trial. G1’s drug trilaciclib was tested in 187 patients with metastatic triple-negative breast cancer, with the patients who took the drug showing a median overall survival […]
Author : News Health
Publish date : 2024-06-24 11:14:18
Copyright for syndicated content belongs to the linked Source.
Categories